Switch to Standard View
MyBreastCancerTreatment.org

Helping Guide Your Early-Stage Breast Cancer Treatment Decisions.

866.941.1214
Get Updates
See and hear from women who have faced invasive breast cancer discussing how they made their treatment decisions. To receive a free DVD of these stories, email Customer Service or call 1-866-ONCOTYPE (1-866-662-6897).

 

Share Your Story

If you have been diagnosed with early-stage breast cancer, we'd love to hear about your personal journey and how you made your treatment decision.

Share Your Story

Is the Oncotype DX® test right for you?

Find out if you could benefit from the Oncotype DX test by completing our simple candidate profile.

Take the Eligibility Quiz

The information presented on this site is intended to provide patients with newly diagnosed invasive or pre-invasive breast cancer (medically known as Ductal Carcinoma In Situ), as well as their friends and family, an opportunity to hear how others have incorporated the information provided by the Oncotype DX® Recurrence Score® in making treatment decisions with their doctors. The personal stories featured on this site selected by Genomic Health, Inc., which offers the Oncotype DX® tests, are not intended to be representative of patients with breast cancer generally, and should not be considered medical advice. Patients should consult their doctor to determine the best treatment decision for their individual disease.

American Society of Clinical Oncology (ASCO) and ASCO are registered trademarks of ASCO; National Comprehensive Cancer Network (NCCN) and NCCN are registered trademarks of NCCN. ASCO and NCCN do not endorse any product or therapy.

Copyright © 2004-2012 Genomic Health, Inc. All rights reserved. Genomic Health, Oncotype, Oncotype DX, Recurrence Score, and Pass It On: Until Every Woman Knows are trademarks of Genomic Health Inc. MyBreastCancerTreatment.org is sponsored by Genomic Health, Inc., a clinical laboratory in Redwood City, California that developed and offers the Oncotype DX® Breast Cancer Assay. Genomic Health is responsible for the content of MyBreastCancerTreatment.org.